Loopworm owns and operates its primary production facility in Bangalore, with a current capacity of 6,000 tons annually.
But deciding if it's a good buy takes a little more looking.
From Adelaide to San Francisco, the biotechnology landscape is shifting – and, in some cases, straining under the weight of ...
Opinion
AI's promise, biotech's peril: How unequal access to computing power threatens medical breakthroughs
One way leads to a future in which AI-driven breakthroughs remain the exclusive domain of pharmaceutical giants with billion-dollar budgets. The other, to a landscape where breakthroughs regularly ...
Dr. Berenika Maciejewicz, a triple-doctor and an expert in longevity, leads the company’s interdisciplinary team to ...
Before Jackson took office at ARPA-H, the agency’s chief data officer departed after disagreeing with the administration’s ...
In the rapidly evolving landscape of global food security, the role of an Agro-Biotechnology R&D Leader has never been more ...
Sanofi is tight-lipped about the future of its underwhelming pact with Denali Therapeutics after the French pharma scrapped what appeared to be the final RIPK1 inhibitor from the deal. | Sanofi is ...
An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation threaten the U.S.’s half-century-long dominance in the biotech sector.
On January 23 around 7:40 a.m. near Grant Elementary School, Santa Monica Waymo's driverless Jaguar I-Pace hit a child who ...
The course seeks to deliver solutions for sustainable agriculture, contributing to food security and environmental ...
Amid steep cuts in federal funding through the National Institutes of Health, medical research institutions are left seeking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results